Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in…
obesity
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to…
Even with access to blockbuster obesity drugs, some people don’t lose weight
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight…